The Comment Period That Could Define Federal Research for a Generation
Submit a comment on a new proposed rule that would introduce ideological constraints to federally funded research by July 13.
On May 29, the Office of Management and Budget published a proposed rule that would give political appointees the authority to block federally funded research on ideological grounds. The research and public health communities have roughly six weeks to respond before the comment window closes.
This is not a routine regulatory update. The proposed revisions to the Uniform Guidance (2 CFR Part 200), the rules that govern how federal grants work across all agencies, represent the most significant attempted restructuring of the federal research funding system in decades. And the comment period, which ends July 13, 2026, is a genuine opportunity to shape what gets finalized. AcademyHealth will be submitting a comment and we’ve also published a public statement on our blog here.
Here is what you need to know, and what you can do.
What the rule would change
Political review of scientific grants. The rule creates a mandatory pre-issuance review in which senior political appointees must confirm that proposed awards are consistent with the President’s policy priorities before grants are made. This is not an expansion of existing agency discretion; it is a structural inversion of it. Under current practice, scientific merit is presumptively sufficient absent a specific reason to override it. Under this rule, political alignment becomes an affirmative threshold every award must clear. Peer review is explicitly subordinated: the rule states it “does not replace agency discretion.” A grant that passes scientific muster could still be blocked.
New ideological conditions on recipients. Applicants and recipients would be required to certify they are not engaged in federally defined unlawful DEI activity. The rule also prohibits funding for activities the administration labels “gender ideology,” a term defined by executive order, not statute. Both provisions are sweeping and vague, and could expose research institutions to liability for work they are currently conducting under existing awards.
Expanded agency authority to cancel grants. The proposed rule strengthens the government’s ability to terminate or modify awards mid-performance for policy-compliance reasons, with weakened due process protections compared to current standards.
Merit defined by administration priorities. The rule directs agencies to prioritize ‘Gold Standard Science’ and reproducible scholarship, principles that are uncontroversial in isolation. But embedded in a framework where scientific merit is assessed alongside compliance with executive priorities, these terms have real implications. They provide cover for defunding research that is methodologically sound but politically inconvenient. The problem is not the words. It is what they authorize.
Restrictions on research dissemination. The rule also tightens conditions on using federal funds for travel and publication costs. For health services researchers, dissemination is not an add-on to the work; it is how evidence reaches the policymakers, clinicians, and systems it is meant to inform. Restrictions on publication and travel funding don’t just create administrative burden. They limit the reach of publicly funded science at the moment it is most needed.
If you are currently holding a federal award
The pre-issuance review affects what gets funded. The mid-award termination authority affects what stays funded, and it deserves direct attention from anyone with an active grant right now.
For long-horizon health services research, longitudinal studies, research networks, investigator pipelines, the ability to terminate or modify a grant mid-stream as political standards shift is a threat of a different order than anything the prior framework contemplated. A researcher three years into a five-year study, a network that has spent years building data infrastructure and community trust: both are now exposed to termination risk tied not to scientific performance but to political compliance.
This rule is not final. The comment period closes July 13, and what gets submitted between now and then will shape what gets finalized. If you hold a federal award, that is reason enough to make sure your voice, or your institution’s voice, is in the record.
What you can do
Federal rulemaking works because agencies are legally required to consider and respond to substantive public comments. Volume matters. Specificity matters more. A flood of comments that document specific, concrete harms from researchers, institutions, professional associations, and patients creates a record that is harder to ignore, harder to defend against in court, and harder to finalize without modification.
The most impactful thing you can do is encourage your institution or professional association to submit comments. A single comment from a major research university, a hospital system, or a professional association carries significant weight because it represents the experience and perspective of a large constituency. If you are a researcher, contact your grants office or government affairs team. If you are affiliated with a professional association, ask whether it is planning to comment, and if not, why not.
If you want to submit your own comment, here’s how to write one that counts:
Be specific. Name the section of the rule you are commenting on (the rule asks commenters to begin with the relevant section number in brackets, e.g., [200.205]). Vague objections are easier to dismiss than targeted ones.
Ground it in your experience. Describe the actual impact on your work, your institution, or your field. How would the pre-issuance review process affect the research you do? What would the DEI certification requirement mean for your institution’s compliance posture? Regulators are required to respond to substantive comments so make yours substantive.
Focus on a few provisions. The rule is long. Comments that address a small number of provisions with real depth are more useful than broad denunciations. Priority targets: Section 200.205 (merit review and pre-issuance review), Section 200.218 (unlawful DEI provision), Section 200.300 (national policy conditions).
Be factual and professional. Comments that read like advocacy documents are easier to dismiss. The goal is to build a record. Describe the problem, cite the specific regulatory text, explain the harm, and propose an alternative or modification.
Submit before the deadline. Comments are due July 13, 2026. Late comments will be considered “only to the extent practicable.” Don’t wait.
Template: Write to your institution’s government affairs office
Not everyone has the bandwidth to write a full regulatory comment, but most people can send an email. Here is a template you can adapt:
Subject: Request for institutional comment on OMB Docket OMB–2026–0034
Dear [Name / Government Affairs / Research Administration Office],
I am writing to urge [Institution Name] to submit comments on OMB’s proposed revisions to the Uniform Guidance (Docket OMB–2026–0034, published May 29, 2026). Comments are due July 13, 2026.
The proposed rule includes significant changes that would affect federally funded research, including a new pre-issuance review requirement that places political appointees in the grant approval process, new certification requirements related to DEI and “gender ideology” that could create compliance uncertainty for our institution, and expanded agency authority to terminate or modify awards.
As an institution [that conducts federally funded research / receives federal grants / trains researchers who depend on federal funding], I believe [Institution Name] has a significant stake in this rulemaking and a meaningful contribution to make. A comment from [our institution / our professional association] would carry real weight with the agency.
I would be glad to discuss this further or connect you with colleagues who are already engaged on this issue.
Thank you for your consideration.
[Your name, title, and affiliation]
Where to submit comments
All comments must be submitted electronically at www.regulations.gov. Search for Docket OMB–2026–0034. Begin each comment with the relevant section number in brackets.
AcademyHealth will be submitting formal comments and will share that submission with our community before the deadline.
Thank you for sharing!